Media - Comunicati Stampa

Per le attività relative a Press & Communication prego contattare:
CITYnet communication
Rome, ITALY
press@sifigroup.com

Visita i nostri social channel!

Comunicati Stampa

Per le attività relative a Press & Communication prego contattare: CITYnet communication Rome, ITALY press@sifigroup.com Visita i nostri social channel!

Comunicati Stampa

SIFI appoints Jelle Kleijn as Global Head of Acanthamoeba Keratitis to globally lead the effort to deliver the first registered treatment for this rare sight-threatening parasitic eye infection. 07 Dicembre 2020

SIFI COMPLETES ENROLLMENT OF THE PHASE III STUDY OF POLIHEXANIDE 0.08% FOR THE TREATMENT OF ACANTHAMOEBA KERATITIS19 Novembre 2020

SIFI REPORTS POSITIVE RESULTS FROM 044/SI PHASE 3 CLINICAL TRIAL FURTHER HIGHLIGHTING STRENGTH OF ITS NETILDEX® FRANCHISE 25 Agosto 2020

UNIVERSITY OF MESSINA AND SIFI ANNOUNCE JOINT PROGRAMME FOR ADVANCED EDUCATION AND RESEARCH 24 Luglio 2020

COVID-19 Emergency, SIFI provides Italian hospital units of ophthalmology with products to treat ocular discomfort and prevent potential risks of infection23 Marzo 2020

Comunicati Stampa

SIFI appoints Jelle Kleijn as Global Head of Acanthamoeba Keratitis to globally lead the effort to deliver the first registered treatment for this rare sight-threatening parasitic eye infection.
07 Dicembre 2020

SIFI COMPLETES ENROLLMENT OF THE PHASE III STUDY OF POLIHEXANIDE 0.08% FOR THE TREATMENT OF ACANTHAMOEBA KERATITIS
19 Novembre 2020

SIFI REPORTS POSITIVE RESULTS FROM 044/SI PHASE 3 CLINICAL TRIAL FURTHER HIGHLIGHTING STRENGTH OF ITS NETILDEX® FRANCHISE
25 Agosto 2020

UNIVERSITY OF MESSINA AND SIFI ANNOUNCE JOINT PROGRAMME FOR ADVANCED EDUCATION AND RESEARCH
24 Luglio 2020

COVID-19 Emergency, SIFI provides Italian hospital units of ophthalmology with products to treat ocular discomfort and prevent potential risks of infection
23 Marzo 2020